Prognostic value of proliferation assay in the luminal, HER2-positive, and triple-negative biologic classes of breast cancer

Por Aleskandarany, Mohammed A, Green, Andrew R, Benhasouna, Ahmed A, Barros, Fabricio F, Neal, Keith, Reis-Filho, Jorge S, Ellis, Ian O, Rakha, Emad A
Publicado em 2012

Camptothecin targets WRN protein: mechanism and relevance in clinical breast cancer

Por Shamanna, Raghavendra A., Lu, Huiming, Croteau, Deborah L., Arora, Arvind, Agarwal, Devika, Ball, Graham, Aleskandarany, Mohammed A., Ellis, Ian O., Pommier, Yves, Madhusudan, Srinivasan, Bohr, Vilhelm A.
Publicado no Oncotarget (2016)

Clinicopathological and functional significance of RECQL1 helicase in sporadic breast cancers

Por Arora, Arvind, Parvathaneni, Swetha, Aleskandarany, Mohammed A, Agarwal, Devika, Ali, Reem, Abdel-Fatah, Tarek, Green, Andrew R, Ball, Graham R, Rakha, Emad A, Ellis, Ian O, Sharma, Sudha, Madhusudan, Srinivasan
Publicado no Mol Cancer Ther (2016)

MYC functions are specific in biological subtypes of breast cancer and confers resistance to endocrine therapy in luminal tumours

Por Green, Andrew R, Aleskandarany, Mohammed A, Agarwal, Devika, Elsheikh, Somaia, Nolan, Christopher C, Diez-Rodriguez, Maria, Macmillan, R Douglas, Ball, Graham R, Caldas, Carlos, Madhusudan, Srinivasan, Ellis, Ian O, Rakha, Emad A
Publicado no Br J Cancer (2016)

Clinicopathological and prognostic significance of RECQL5 helicase expression in breast cancers

Por Arora, Arvind, Abdel-Fatah, Tarek M.A., Agarwal, Devika, Doherty, Rachel, Croteau, Deborah L., Moseley, Paul M., Hameed, Khalid, Green, Andrew, Aleskandarany, Mohammed A., Rakha, Emad A., Patterson, Karl, Ball, Graham, Chan, Stephen Y.T., Ellis, Ian O., Bohr, Vilhelm A., Bryant, Helen E., Madhusudan, Srinivasan
Publicado no Carcinogenesis (2016)